Krónikus limfoid leukémia (CLL): vizsgálatok itt: Egyesült Királyság
34 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 1. fázisTaking peopleA Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
- Where
- Glasgow, Leeds, Liverpool, London, Manchester, Oxford, Plymouth, Southampton, Sutton
- Életkor
- 18 év and over
- People
- 572 worldwide
- Run by
- Nurix Therapeutics, Inc.
See details and how to joinNCT05131022 · EU 2023-510541-25-00 - 3. fázisTaking peopleGlobal Trial in APG2575 for Patients With CLL/SLL
- Where
- Birmingham, Bournemouth, Liverpool, London, Manchester, Stoke-on-Trent, Swansea, West Bromwich, Wolverhampton
- Életkor
- 18 év to 99 év
- People
- 400 worldwide
- Run by
- Ascentage Pharma Group Inc.
See details and how to joinNCT06104566 · EU 2023-508005-24-00 - 2. fázisTaking peopleMethods of T Cell Depletion Trial (MoTD)
- Where
- Birmingham, Bristol, Cambridge, Cardiff, Glasgow, Leeds, London, Manchester, Newcastle upon Tyne, Nottingham, Oxford, Plymouth, Sheffield, Sutton
- Életkor
- 16 év to 70 év
- People
- 400
- Run by
- University of Birmingham
See details and how to joinNCT04888741 - 3. fázisTaking peopleA Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)
- Where
- Nottingham
- Életkor
- 18 év and over
- People
- 170 worldwide
- Run by
- AbbVie
See details and how to joinNCT06428019 · EU 2024-512147-23-00 - 4. fázisTaking peopleA Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib
- Where
- Leeds, Oxford, Plymouth
- Életkor
- 18 év and over
- People
- 787 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06876649 - 4. fázisTaking peopleA Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma
- Where
- Leeds, Oxford, Plymouth
- Életkor
- 18 év and over
- People
- 279 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06876662 - 2. fázisTaking peopleStudy to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)
- Where
- Blackpool, Leeds, Norwich
- Életkor
- 18 év and over
- People
- 75 worldwide
- Run by
- AbbVie
See details and how to joinNCT04895436 · EU 2023-504599-10-00 - 2. fázisTaking peopleIntestinal Microbiota Transplant Prior to Allogeneic Stem Cell Transplant (MAST) Trial
- Where
- Birmingham, Leeds, London, Manchester
- Életkor
- 18 év and over
- People
- 50
- Run by
- Imperial College London
See details and how to joinNCT06355583 - 1/2. fázisTaking peopleSafety and Efficacy of KRT-232 in Combination With Acalabrutinib in Subjects With R/R DLBCL or R/R CLL
- Where
- Leeds, London, Southampton
- Életkor
- 18 év and over
- People
- 84 worldwide
- Run by
- Kartos Therapeutics, Inc.
See details and how to joinNCT04502394